Yeheng Zhu
Bristol-Myers Squibb (Germany)(DE)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Neurotransmitter Receptor Influence on Behavior, Cannabis and Cannabinoid Research, Phosphodiesterase function and regulation
Most-Cited Works
- → Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)(2006)151 cited
- → Overcoming Limitations in Decarboxylative Arylation via Ag–Ni Electrocatalysis(2022)132 cited
- → Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy(2021)97 cited
- → N-3-Substituted Imidazoquinazolinones: Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction(2000)45 cited
- → Discovery of pyrazine carboxamide CB1 antagonists: The introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series(2007)36 cited
- → Optimization of Substituted N-3-Benzylimidazoquinazolinone Sulfonamides as Potent and Selective PDE5 Inhibitors(2000)31 cited
- → Synthesis of triazolopyridines and triazolopyrimidines using a modified Mitsunobu reaction(2007)17 cited
- → Reduction of Site-Specific CYP3A-Mediated Metabolism for Dual Angiotensin and Endothelin Receptor Antagonists in Various in Vitro Systems and in Cynomolgus Monkeys(2007)17 cited
- → Amination of Nitro-Substituted Heteroarenes by Nucleophilic Substitution of Hydrogen(2022)13 cited
- → Reductions in log P Improved Protein Binding and Clearance Predictions Enabling the Prospective Design of Cannabinoid Receptor (CB1) Antagonists with Desired Pharmacokinetic Properties(2013)11 cited